Okano H - Search Results

1

Natural course of cavernous hepatic hemangioma.

Okano H, Shiraki K, Inoue H, Ito T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Nakano T. Okano H, et al. Oncol Rep. 2001 Mar-Apr;8(2):411-4. doi: 10.3892/or.8.2.411. Oncol Rep. 2001. PMID: 11182065

2

Laparoscopic microwave coagulation therapy for small hepatocellular carcinoma on the liver surface.

Okano H, Shiraki K, Inoue H, Kawakita T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Nakano T. Okano H, et al. Oncol Rep. 2002 Sep-Oct;9(5):1001-4. Oncol Rep. 2002. PMID: 12168063

3

Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure.

Ohmori S, Shiraki K, Inoue H, Okano H, Yamanaka T, Deguchi M, Sakai T, Takase K, Nakano T, Tameda Y. Ohmori S, et al. Among authors: okano h. Hepatogastroenterology. 2003 Sep-Oct;50(53):1531-4. Hepatogastroenterology. 2003. PMID: 14571779

4

"Variable echo sign" (ultrasonographical alteration of echogenicity) in cavernous hepatic hemangioma.

Okano H, Shiraki K, Inoue H, Ito T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Takase K, Nakano T. Okano H, et al. Int J Oncol. 2001 Aug;19(2):337-40. doi: 10.3892/ijo.19.2.337. Int J Oncol. 2001. PMID: 11445848

5

Combining transcatheter arterial chemoembolization with percutaneous ethanol injection therapy for small size hepatocellular carcinoma.

Okano H, Shiraki K, Inoue H, Ito T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Nakano T. Okano H, et al. Int J Oncol. 2001 Nov;19(5):909-12. doi: 10.3892/ijo.19.5.909. Int J Oncol. 2001. PMID: 11604987

6

Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.

Okano H, Shiraki K, Inoue H, Ito T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Nakano T. Okano H, et al. Anticancer Res. 2001 Jul-Aug;21(4B):2979-82. Anticancer Res. 2001. PMID: 11712797

7

Laparoscopic ethanol injection therapy for hepatocellular carcinoma.

Okano H, Shiraki K, Inoue H, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Nakano T. Okano H, et al. Int J Oncol. 2002 Feb;20(2):267-71. Int J Oncol. 2002. PMID: 11788887

8

Peroxisome proliferator-activated receptor gamma augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma.

Okano H, Shiraki K, Inoue H, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T. Okano H, et al. Anticancer Drugs. 2002 Jan;13(1):59-65. doi: 10.1097/00001813-200201000-00007. Anticancer Drugs. 2002. PMID: 11914642

9

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.

Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T. Sakai T, et al. Among authors: okano h. Int J Mol Med. 2002 Aug;10(2):201-4. Int J Mol Med. 2002. PMID: 12119559

10

HBV subtype as a marker of the clinical course of chronic HBV infection in Japanese patients.

Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Fujioka H, Takase K, Tameda Y, Nakano T. Sakai T, et al. Among authors: okano h. J Med Virol. 2002 Oct;68(2):175-81. doi: 10.1002/jmv.10180. J Med Virol. 2002. PMID: 12210405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,703 results

Search Page

Filters